Publication 4/01/2008

Novel AAV serotypes for improved ocular gene transfer.

Lebherz C, Maguire A, Tang W, Bennett J, Wilson JM

The Journal Of Gene Medicine

Publication 5/02/2007

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.

Lebherz C, Sanmiguel J, Wilson JM, Rader DJ

Cardiovascular Diabetology

Publication 12/01/2005

Creatine kinase, a magnetic resonance-detectable marker gene for quantification of liver-directed gene transfer.

Li Z, Qiao H, Lebherz C, Choi SR, Zhou X, Gao G, Kung HF, Rader DJ, Wilson JM, Glickson JD, Zhou R

Human Gene Therapy

Publication 8/01/2005

No evidence for tumorigenesis of AAV vectors in a large-scale study in mice.

Bell P, Wang L, Lebherz C, Flieder DB, Bove MS, Wu D, Gao GP, Wilson JM, Wivel NA

Molecular Therapy : The Journal Of The American Society Of Gene Therapy

Publication 5/01/2005

Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha.

Lehrke M, Lebherz C, Millington SC, Guan HP, Millar J, Rader DJ, Wilson JM, Lazar MA

Cell Metabolism

Publication 4/01/2005

Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor.

Lebherz C, Maguire AM, Auricchio A, Tang W, Aleman TS, Wei Z, Grant R, Cideciyan AV, Jacobson SG, Wilson JM, Bennett J

Diabetes